CA Patent

CA2930464A1 — A process for the preparation of regadenoson

Assigned to Scinopharm Taiwan Ltd · Expires 2015-06-18 · 11y expired

What this patent protects

The present invention provides novel processes for the preparation of regadenoson having the formula (I). In some embodiments, the intermediates for the synthesis of regadenoson are also provided.

USPTO Abstract

The present invention provides novel processes for the preparation of regadenoson having the formula (I). In some embodiments, the intermediates for the synthesis of regadenoson are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA2930464A1
Jurisdiction
CA
Classification
—
Expires
2015-06-18
Drug substance claim
No
Drug product claim
No
Assignee
Scinopharm Taiwan Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.